Adenosine A2A receptor as a drug discovery target

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• The adenosine A2A receptor (A2A R) is a G-protein-coupled receptor (GPCR) with significant therapeutic potential.
• Extensive research over decades highlights its importance in various physiological processes.

Purpose of the Study:

• To provide a comprehensive overview of adenosine A2A receptor distribution, signaling pathways, pharmacology, and molecular structure.
• To summarize and discuss structure-activity relationships (SAR) of key A2A receptor agonists and antagonists.
• To update on A2A ligands in clinical studies and marketed A2A agonists.

Main Methods:

• Literature review of published studies on adenosine A2A receptors.
• Analysis of signaling pathways and molecular structure.
• Summary of SAR for A2A agonists and antagonists.
• Review of clinical trial data and marketed drugs.

Main Results:

• Detailed description of A2A receptor distribution and signaling mechanisms.
• Identification of key structural features influencing A2A receptor ligand binding.
• Summary of SAR for major classes of A2A agonists and antagonists.
• Update on the clinical status of various A2A ligands, including approved drugs like adenosine and regadenoson.

Conclusions:

• The adenosine A2A receptor remains a promising target for therapeutic intervention.
• Understanding its structure, signaling, and ligand interactions is crucial for drug development.
• Ongoing clinical investigations suggest continued interest in A2A R-targeted therapies.